nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Sulfaphenazole—Sulfasalazine—ankylosing spondylitis	0.232	0.342	CrCrCtD
Sulfamethoxazole—Sulfadiazine—Sulfasalazine—ankylosing spondylitis	0.232	0.342	CrCrCtD
Sulfamethoxazole—Sulfapyridine—Sulfasalazine—ankylosing spondylitis	0.214	0.316	CrCrCtD
Sulfamethoxazole—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0768	0.275	CbGbCtD
Sulfamethoxazole—ALB—Prednisone—ankylosing spondylitis	0.0458	0.164	CbGbCtD
Sulfamethoxazole—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0237	0.085	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—ankylosing spondylitis	0.023	0.0825	CbGbCtD
Sulfamethoxazole—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0221	0.0793	CbGbCtD
Sulfamethoxazole—CYP3A4—Triamcinolone—ankylosing spondylitis	0.018	0.0645	CbGbCtD
Sulfamethoxazole—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0154	0.0553	CbGbCtD
Sulfamethoxazole—CYP3A4—Betamethasone—ankylosing spondylitis	0.0154	0.0553	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisolone—ankylosing spondylitis	0.0152	0.0546	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisone—ankylosing spondylitis	0.0144	0.0515	CbGbCtD
Sulfamethoxazole—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00897	0.0322	CbGbCtD
Sulfamethoxazole—Neuritis—Betamethasone—ankylosing spondylitis	0.000512	0.012	CcSEcCtD
Sulfamethoxazole—Neuritis—Dexamethasone—ankylosing spondylitis	0.000512	0.012	CcSEcCtD
Sulfamethoxazole—Eruption—Methotrexate—ankylosing spondylitis	0.000452	0.0106	CcSEcCtD
Sulfamethoxazole—Neuritis—Prednisone—ankylosing spondylitis	0.000446	0.0104	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Methotrexate—ankylosing spondylitis	0.000412	0.00963	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.000342	0.00798	CcSEcCtD
Sulfamethoxazole—Purpura—Triamcinolone—ankylosing spondylitis	0.000317	0.00741	CcSEcCtD
Sulfamethoxazole—Oliguria—Methotrexate—ankylosing spondylitis	0.000302	0.00705	CcSEcCtD
Sulfamethoxazole—Glossitis—Methotrexate—ankylosing spondylitis	0.000302	0.00705	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.000294	0.00687	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000282	0.00658	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Prednisone—ankylosing spondylitis	0.00027	0.00631	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000261	0.0061	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000259	0.00605	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000258	0.00604	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000251	0.00587	CcSEcCtD
Sulfamethoxazole—Purpura—Prednisone—ankylosing spondylitis	0.000251	0.00586	CcSEcCtD
Sulfamethoxazole—Infestation—Methylprednisolone—ankylosing spondylitis	0.000235	0.00549	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000235	0.00549	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000231	0.0054	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00023	0.00538	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00023	0.00537	CcSEcCtD
Sulfamethoxazole—Polyuria—Methotrexate—ankylosing spondylitis	0.00023	0.00537	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000214	0.005	CcSEcCtD
Sulfamethoxazole—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00021	0.00491	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000209	0.0049	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000209	0.0049	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000207	0.00484	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Prednisone—ankylosing spondylitis	0.000205	0.00478	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000197	0.00461	CcSEcCtD
Sulfamethoxazole—Neutropenia—Prednisone—ankylosing spondylitis	0.000195	0.00456	CcSEcCtD
Sulfamethoxazole—Hallucination—Betamethasone—ankylosing spondylitis	0.000191	0.00446	CcSEcCtD
Sulfamethoxazole—Hallucination—Dexamethasone—ankylosing spondylitis	0.000191	0.00446	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000191	0.00445	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00019	0.00444	CcSEcCtD
Sulfamethoxazole—Ataxia—Methotrexate—ankylosing spondylitis	0.00019	0.00444	CcSEcCtD
Sulfamethoxazole—Depression—Prednisone—ankylosing spondylitis	0.000186	0.00434	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000185	0.00432	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000184	0.00429	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisolone—ankylosing spondylitis	0.000183	0.00427	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000182	0.00426	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000182	0.00425	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisolone—ankylosing spondylitis	0.00018	0.0042	CcSEcCtD
Sulfamethoxazole—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000179	0.00419	CcSEcCtD
Sulfamethoxazole—Eye disorder—Betamethasone—ankylosing spondylitis	0.000179	0.00419	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisolone—ankylosing spondylitis	0.000173	0.00405	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000173	0.00404	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000171	0.004	CcSEcCtD
Sulfamethoxazole—Angioedema—Triamcinolone—ankylosing spondylitis	0.000168	0.00393	CcSEcCtD
Sulfamethoxazole—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000168	0.00392	CcSEcCtD
Sulfamethoxazole—Hallucination—Prednisone—ankylosing spondylitis	0.000166	0.00388	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000166	0.00387	CcSEcCtD
Sulfamethoxazole—Vertigo—Triamcinolone—ankylosing spondylitis	0.000165	0.00386	CcSEcCtD
Sulfamethoxazole—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000165	0.00386	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000164	0.00384	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000163	0.00382	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—ankylosing spondylitis	0.000163	0.00381	CcSEcCtD
Sulfamethoxazole—Cough—Triamcinolone—ankylosing spondylitis	0.000161	0.00375	CcSEcCtD
Sulfamethoxazole—Convulsion—Triamcinolone—ankylosing spondylitis	0.000159	0.00373	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000159	0.00372	CcSEcCtD
Sulfamethoxazole—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000159	0.00372	CcSEcCtD
Sulfamethoxazole—Myalgia—Triamcinolone—ankylosing spondylitis	0.000157	0.00366	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—ankylosing spondylitis	0.000156	0.00366	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000156	0.00365	CcSEcCtD
Sulfamethoxazole—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000156	0.00365	CcSEcCtD
Sulfamethoxazole—Eye disorder—Prednisone—ankylosing spondylitis	0.000156	0.00365	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—ankylosing spondylitis	0.000156	0.00363	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000156	0.00363	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000155	0.00363	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—ankylosing spondylitis	0.000155	0.00362	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000154	0.0036	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—ankylosing spondylitis	0.000153	0.00357	CcSEcCtD
Sulfamethoxazole—Angioedema—Betamethasone—ankylosing spondylitis	0.000153	0.00357	CcSEcCtD
Sulfamethoxazole—Angioedema—Dexamethasone—ankylosing spondylitis	0.000153	0.00357	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—ankylosing spondylitis	0.000152	0.00354	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Prednisone—ankylosing spondylitis	0.000151	0.00353	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00015	0.00351	CcSEcCtD
Sulfamethoxazole—Vertigo—Dexamethasone—ankylosing spondylitis	0.00015	0.00351	CcSEcCtD
Sulfamethoxazole—Vertigo—Betamethasone—ankylosing spondylitis	0.00015	0.00351	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00015	0.0035	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisolone—ankylosing spondylitis	0.000148	0.00345	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000147	0.00344	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000147	0.00344	CcSEcCtD
Sulfamethoxazole—Mental disorder—Prednisone—ankylosing spondylitis	0.000146	0.00342	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000146	0.0034	CcSEcCtD
Sulfamethoxazole—Malnutrition—Prednisone—ankylosing spondylitis	0.000145	0.0034	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000145	0.00339	CcSEcCtD
Sulfamethoxazole—Convulsion—Dexamethasone—ankylosing spondylitis	0.000145	0.00338	CcSEcCtD
Sulfamethoxazole—Convulsion—Betamethasone—ankylosing spondylitis	0.000145	0.00338	CcSEcCtD
Sulfamethoxazole—Myalgia—Betamethasone—ankylosing spondylitis	0.000142	0.00332	CcSEcCtD
Sulfamethoxazole—Myalgia—Dexamethasone—ankylosing spondylitis	0.000142	0.00332	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—ankylosing spondylitis	0.00014	0.00326	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000138	0.00322	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000137	0.0032	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000137	0.0032	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000137	0.00319	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000136	0.00319	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000136	0.00319	CcSEcCtD
Sulfamethoxazole—Insomnia—Triamcinolone—ankylosing spondylitis	0.000136	0.00318	CcSEcCtD
Sulfamethoxazole—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000136	0.00317	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000134	0.00313	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000134	0.00312	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000134	0.00312	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000133	0.00312	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000133	0.00312	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisone—ankylosing spondylitis	0.000133	0.00311	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000132	0.00309	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000132	0.00309	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000132	0.00308	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisone—ankylosing spondylitis	0.000131	0.00305	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—ankylosing spondylitis	0.00013	0.00305	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—ankylosing spondylitis	0.00013	0.00304	CcSEcCtD
Sulfamethoxazole—Anorexia—Betamethasone—ankylosing spondylitis	0.00013	0.00304	CcSEcCtD
Sulfamethoxazole—Anorexia—Dexamethasone—ankylosing spondylitis	0.00013	0.00304	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisolone—ankylosing spondylitis	0.00013	0.00303	CcSEcCtD
Sulfamethoxazole—Fatigue—Triamcinolone—ankylosing spondylitis	0.000129	0.00303	CcSEcCtD
Sulfamethoxazole—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000129	0.00302	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000126	0.00295	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisone—ankylosing spondylitis	0.000126	0.00294	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000126	0.00294	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—ankylosing spondylitis	0.000125	0.00293	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000124	0.0029	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000124	0.0029	CcSEcCtD
Sulfamethoxazole—Myalgia—Prednisone—ankylosing spondylitis	0.000124	0.00289	CcSEcCtD
Sulfamethoxazole—Arthralgia—Prednisone—ankylosing spondylitis	0.000124	0.00289	CcSEcCtD
Sulfamethoxazole—Insomnia—Betamethasone—ankylosing spondylitis	0.000123	0.00288	CcSEcCtD
Sulfamethoxazole—Insomnia—Dexamethasone—ankylosing spondylitis	0.000123	0.00288	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000123	0.00287	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000123	0.00286	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—ankylosing spondylitis	0.000122	0.00286	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—ankylosing spondylitis	0.000122	0.00284	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00012	0.00281	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00012	0.0028	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00012	0.0028	CcSEcCtD
Sulfamethoxazole—Urticaria—Triamcinolone—ankylosing spondylitis	0.000119	0.00279	CcSEcCtD
Sulfamethoxazole—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000119	0.00278	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000119	0.00278	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000119	0.00277	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000118	0.00277	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000118	0.00277	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000118	0.00277	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000118	0.00275	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000118	0.00275	CcSEcCtD
Sulfamethoxazole—Fatigue—Dexamethasone—ankylosing spondylitis	0.000117	0.00275	CcSEcCtD
Sulfamethoxazole—Fatigue—Betamethasone—ankylosing spondylitis	0.000117	0.00275	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000116	0.00272	CcSEcCtD
Sulfamethoxazole—Skin disorder—Prednisone—ankylosing spondylitis	0.000115	0.00269	CcSEcCtD
Sulfamethoxazole—Anorexia—Prednisone—ankylosing spondylitis	0.000113	0.00264	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000111	0.0026	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000111	0.0026	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000111	0.00259	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00011	0.00258	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—ankylosing spondylitis	0.000109	0.00255	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—ankylosing spondylitis	0.000109	0.00254	CcSEcCtD
Sulfamethoxazole—Urticaria—Dexamethasone—ankylosing spondylitis	0.000108	0.00253	CcSEcCtD
Sulfamethoxazole—Urticaria—Betamethasone—ankylosing spondylitis	0.000108	0.00253	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000108	0.00253	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisolone—ankylosing spondylitis	0.000108	0.00252	CcSEcCtD
Sulfamethoxazole—Asthenia—Triamcinolone—ankylosing spondylitis	0.000108	0.00252	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000108	0.00252	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000108	0.00252	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000108	0.00252	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000108	0.00252	CcSEcCtD
Sulfamethoxazole—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000108	0.00251	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisone—ankylosing spondylitis	0.000107	0.00251	CcSEcCtD
Sulfamethoxazole—Pruritus—Triamcinolone—ankylosing spondylitis	0.000106	0.00248	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—ankylosing spondylitis	0.000106	0.00248	CcSEcCtD
Sulfamethoxazole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000106	0.00248	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—ankylosing spondylitis	0.000105	0.00246	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Prednisone—ankylosing spondylitis	0.000104	0.00244	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—ankylosing spondylitis	0.000103	0.00242	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—ankylosing spondylitis	0.000103	0.00242	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Prednisone—ankylosing spondylitis	0.000103	0.00241	CcSEcCtD
Sulfamethoxazole—Rash—Prednisolone—ankylosing spondylitis	0.000103	0.00241	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisolone—ankylosing spondylitis	0.000103	0.0024	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000103	0.0024	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000103	0.0024	CcSEcCtD
Sulfamethoxazole—Fatigue—Prednisone—ankylosing spondylitis	0.000102	0.00239	CcSEcCtD
Sulfamethoxazole—Headache—Prednisolone—ankylosing spondylitis	0.000102	0.00239	CcSEcCtD
Sulfamethoxazole—Dizziness—Triamcinolone—ankylosing spondylitis	9.93e-05	0.00232	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	9.92e-05	0.00232	CcSEcCtD
Sulfamethoxazole—Dizziness—Methylprednisolone—ankylosing spondylitis	9.91e-05	0.00232	CcSEcCtD
Sulfamethoxazole—Asthenia—Betamethasone—ankylosing spondylitis	9.78e-05	0.00229	CcSEcCtD
Sulfamethoxazole—Asthenia—Dexamethasone—ankylosing spondylitis	9.78e-05	0.00229	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—ankylosing spondylitis	9.73e-05	0.00227	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	9.71e-05	0.00227	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	9.7e-05	0.00227	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisolone—ankylosing spondylitis	9.7e-05	0.00227	CcSEcCtD
Sulfamethoxazole—Pruritus—Dexamethasone—ankylosing spondylitis	9.64e-05	0.00225	CcSEcCtD
Sulfamethoxazole—Pruritus—Betamethasone—ankylosing spondylitis	9.64e-05	0.00225	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—ankylosing spondylitis	9.63e-05	0.00225	CcSEcCtD
Sulfamethoxazole—Vomiting—Triamcinolone—ankylosing spondylitis	9.55e-05	0.00223	CcSEcCtD
Sulfamethoxazole—Vomiting—Methylprednisolone—ankylosing spondylitis	9.53e-05	0.00223	CcSEcCtD
Sulfamethoxazole—Rash—Triamcinolone—ankylosing spondylitis	9.47e-05	0.00221	CcSEcCtD
Sulfamethoxazole—Dermatitis—Triamcinolone—ankylosing spondylitis	9.46e-05	0.00221	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—ankylosing spondylitis	9.45e-05	0.00221	CcSEcCtD
Sulfamethoxazole—Rash—Methylprednisolone—ankylosing spondylitis	9.45e-05	0.00221	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methylprednisolone—ankylosing spondylitis	9.44e-05	0.00221	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisone—ankylosing spondylitis	9.43e-05	0.0022	CcSEcCtD
Sulfamethoxazole—Headache—Triamcinolone—ankylosing spondylitis	9.41e-05	0.0022	CcSEcCtD
Sulfamethoxazole—Headache—Methylprednisolone—ankylosing spondylitis	9.39e-05	0.00219	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Prednisone—ankylosing spondylitis	9.38e-05	0.00219	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Prednisone—ankylosing spondylitis	9.38e-05	0.00219	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dexamethasone—ankylosing spondylitis	9.32e-05	0.00218	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Betamethasone—ankylosing spondylitis	9.32e-05	0.00218	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	9.04e-05	0.00211	CcSEcCtD
Sulfamethoxazole—Dizziness—Dexamethasone—ankylosing spondylitis	9.01e-05	0.00211	CcSEcCtD
Sulfamethoxazole—Dizziness—Betamethasone—ankylosing spondylitis	9.01e-05	0.00211	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—ankylosing spondylitis	8.97e-05	0.0021	CcSEcCtD
Sulfamethoxazole—Nausea—Triamcinolone—ankylosing spondylitis	8.92e-05	0.00209	CcSEcCtD
Sulfamethoxazole—Nausea—Methylprednisolone—ankylosing spondylitis	8.9e-05	0.00208	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—ankylosing spondylitis	8.84e-05	0.00207	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisone—ankylosing spondylitis	8.74e-05	0.00204	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—ankylosing spondylitis	8.73e-05	0.00204	CcSEcCtD
Sulfamethoxazole—Vomiting—Betamethasone—ankylosing spondylitis	8.66e-05	0.00203	CcSEcCtD
Sulfamethoxazole—Vomiting—Dexamethasone—ankylosing spondylitis	8.66e-05	0.00203	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—ankylosing spondylitis	8.62e-05	0.00202	CcSEcCtD
Sulfamethoxazole—Rash—Dexamethasone—ankylosing spondylitis	8.59e-05	0.00201	CcSEcCtD
Sulfamethoxazole—Rash—Betamethasone—ankylosing spondylitis	8.59e-05	0.00201	CcSEcCtD
Sulfamethoxazole—Dermatitis—Betamethasone—ankylosing spondylitis	8.58e-05	0.00201	CcSEcCtD
Sulfamethoxazole—Dermatitis—Dexamethasone—ankylosing spondylitis	8.58e-05	0.00201	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	8.56e-05	0.002	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—ankylosing spondylitis	8.55e-05	0.002	CcSEcCtD
Sulfamethoxazole—Headache—Betamethasone—ankylosing spondylitis	8.54e-05	0.002	CcSEcCtD
Sulfamethoxazole—Headache—Dexamethasone—ankylosing spondylitis	8.54e-05	0.002	CcSEcCtD
Sulfamethoxazole—Asthenia—Prednisone—ankylosing spondylitis	8.51e-05	0.00199	CcSEcCtD
Sulfamethoxazole—Pruritus—Prednisone—ankylosing spondylitis	8.4e-05	0.00196	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Prednisone—ankylosing spondylitis	8.12e-05	0.0019	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.11e-05	0.0019	CcSEcCtD
Sulfamethoxazole—Nausea—Betamethasone—ankylosing spondylitis	8.09e-05	0.00189	CcSEcCtD
Sulfamethoxazole—Nausea—Dexamethasone—ankylosing spondylitis	8.09e-05	0.00189	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—ankylosing spondylitis	7.88e-05	0.00184	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisone—ankylosing spondylitis	7.85e-05	0.00183	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—ankylosing spondylitis	7.84e-05	0.00183	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—ankylosing spondylitis	7.84e-05	0.00183	CcSEcCtD
Sulfamethoxazole—Vomiting—Prednisone—ankylosing spondylitis	7.55e-05	0.00176	CcSEcCtD
Sulfamethoxazole—Rash—Prednisone—ankylosing spondylitis	7.48e-05	0.00175	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisone—ankylosing spondylitis	7.48e-05	0.00175	CcSEcCtD
Sulfamethoxazole—Headache—Prednisone—ankylosing spondylitis	7.43e-05	0.00174	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.31e-05	0.00171	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—ankylosing spondylitis	7.12e-05	0.00166	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisone—ankylosing spondylitis	7.05e-05	0.00165	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—ankylosing spondylitis	7.02e-05	0.00164	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—ankylosing spondylitis	6.79e-05	0.00159	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—ankylosing spondylitis	6.56e-05	0.00153	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—ankylosing spondylitis	6.31e-05	0.00147	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—ankylosing spondylitis	6.25e-05	0.00146	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—ankylosing spondylitis	6.25e-05	0.00146	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—ankylosing spondylitis	6.21e-05	0.00145	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—ankylosing spondylitis	5.89e-05	0.00138	CcSEcCtD
